TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Framework for Transition products (Axitinib and Eltrombopag)

No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Transition products (Axitinib and Eltrombopag)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
22.8Bids / Report
7.7% of reports have one bid
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
Anna Freud1 win£5,862,540
Anglia Ruskin University1 win£4,809,159
NHS Shared Business Services Limited1 win£4,393,727
Pearson Professional Assessments Limited1 win£4,374,320
Timewise Foundation CIC1 win£166,667
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published4 Sept 2025, 17:47 BST
Last source update4 Sept 2025, 17:47 BST
Recurring procurementNot published
ClassificationNot published
Delivery areaLocation not published
OCIDocds-h6vhtk-050bb9
What is being bought
Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.
What changed
From the official release history
  1. Official notice release published
    4 Sept 2025, 17:47 BST
  2. tender value changed
    30 Jul 2025, 11:23 BST
  3. Status changed to complete
    30 Jul 2025, 11:23 BST
  4. Official notice release published
    30 Jul 2025, 11:23 BST
  5. Submission deadline changed to published date
    30 Jul 2025, 11:23 BST
  6. Published value updated to £80,909,200
    4 Jun 2025, 15:34 BST
  7. Status changed to active
    4 Jun 2025, 15:34 BST
  8. Official notice release published
    4 Jun 2025, 15:34 BST
  9. Submission deadline changed to 4 Jul 2025, 13:00 BST
    4 Jun 2025, 15:34 BST
  10. Published value updated to £60,945,000
    1 May 2025, 16:18 BST
  11. Status changed to planning
    1 May 2025, 16:18 BST
  12. Official notice release published
    1 May 2025, 16:18 BST
  13. Buyer information updated
    1 May 2025, 16:18 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    4 Sept 2025, 17:47 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 18 Aug 2025, 00:00 BST · £52,385,000
Commercial outcome and competition
Awards
DR REDDY'S LABORATORIES (UK) LIMITED, NOVARTIS PHARMACEUTICALS UK LIMITED, Perennial Pharma Ltd, Pfizer Ltd, TEVA UK LIMITED, THORNTON & ROSS LIMITED, WOCKHARDT UK HOLDINGS LTD
Not published · Not published · active
Contracts
NHS National Framework for Transition products (Axitinib and Eltrombopag)
£52,385,000 · signed 18 Aug 2025, 00:00 BST · active
Contract period: 1 Oct 2025, 00:00 BST — 31 Jan 2027, 23:59 GMT
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS England

Contracting authority GB-PPON-PDPT-3135-BWWY
View buyer profile
Documents (1)
Official links; attachments are not copied

  • Not published

    tender
    conflictOfInterest
Related procedures (0)
No data
No related procedures published